FOOYA! is a gamified medical
mobile App for children and young adults based on the pioneering digital
vaccine platform developed by Friends Learn, which is a Silicon Valley and
Chennai based research translation and innovation partner of the Digital Vaccine Project at Carnegie Mellon University. It
is a product of fundamental breakthroughs in neurocognitive computing and
neuro-behaviour-physiological modulation through gamified immersive mobile virtual reality (VR) based neurocognitive training, to prevent metabolic diseases
such as diabetes, hypertension, cardiovascular disease and certain types of
Cancer. It works non-invasively by stimulating biological mechanistic pathways
in the gut-brain axes, as well as through the immune system, through VR based
gamified experiential neurocognitive training and implicit learning models.
FOOYA! Was featured as a case study of cutting
edge research at the 2018 SBCC Conference by Johns Hopkins University Bloomberg
School of Public Health, UNICEF, and BBC Action. It delivers a unique
health education curriculum, which is made available through select accredited school partners, in India and around the world, to protect the health of
children and their families through clinically proven, safe, and
ethically developed scientific innovation.
CCC-I collaborated with this world-leading
consortium of researchers from Carnegie Mellon University, Hofstra University
and Johns Hopkins University Bloomberg School of Public Health. Results from
the randomized controlled field trial designed and undertaken by CCC-I
researchers in a school setting have been published
in the top peer-reviewed journal for digital medicine - JMIR mHealth and uHealth. The team found statistically significant evidence of positive
neuro-behavior health outcomes in children caused by the first 20-minute dose
exposure. The research team also found a strong effect sustained as a result of
a booster dose after a week. No harmful side effects were reported during the
study and during follow-ups.
